| Dr Roger K Khouri, MD | |
|
2734 Sw 37th Ave, Coconut Grove, FL 33133-2728 | |
| (305) 642-4260 | |
| (305) 426-3329 |
| Full Name | Dr Roger K Khouri |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 43 Years |
| Location | 2734 Sw 37th Ave, Coconut Grove, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740232784 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Miami Hand Pllc | 3476686338 | 9 |
| Miami Breast Center Llc | 3678756467 | 8 |
| Susana Leal Khouri Md Pa | 5193871838 | 7 |
News Archive
They call themselves quiet professionals - an elite, highly trained group of military experts known for their strength, stealth and speed. Some of their training is coming from doctors and nurses at the Virginia Commonwealth University Medical Center.
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.
European scientists recently discovered a novel therapy to treat a subgroup of patients with hereditary breast/ovarian cancer. Both the EU and the US have approved an accelerated procedure to market this promising new treatment with few side effects.
Topera Medical today announced that its FDA-cleared RhythmView 3D mapping and diagnostic system will be featured in 16 scientific presentations at the 33rd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 9-12 in Boston.
› Verified 9 days ago
| Entity Name | Susana Leal Khouri Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275567133 PECOS PAC ID: 5193871838 Enrollment ID: O20090921000680 |
News Archive
They call themselves quiet professionals - an elite, highly trained group of military experts known for their strength, stealth and speed. Some of their training is coming from doctors and nurses at the Virginia Commonwealth University Medical Center.
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.
European scientists recently discovered a novel therapy to treat a subgroup of patients with hereditary breast/ovarian cancer. Both the EU and the US have approved an accelerated procedure to market this promising new treatment with few side effects.
Topera Medical today announced that its FDA-cleared RhythmView 3D mapping and diagnostic system will be featured in 16 scientific presentations at the 33rd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 9-12 in Boston.
› Verified 9 days ago
| Entity Name | Miami Hand Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295062610 PECOS PAC ID: 3476686338 Enrollment ID: O20100729000790 |
News Archive
They call themselves quiet professionals - an elite, highly trained group of military experts known for their strength, stealth and speed. Some of their training is coming from doctors and nurses at the Virginia Commonwealth University Medical Center.
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.
European scientists recently discovered a novel therapy to treat a subgroup of patients with hereditary breast/ovarian cancer. Both the EU and the US have approved an accelerated procedure to market this promising new treatment with few side effects.
Topera Medical today announced that its FDA-cleared RhythmView 3D mapping and diagnostic system will be featured in 16 scientific presentations at the 33rd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 9-12 in Boston.
› Verified 9 days ago
| Entity Name | Miami Breast Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063726099 PECOS PAC ID: 3678756467 Enrollment ID: O20110401000262 |
News Archive
They call themselves quiet professionals - an elite, highly trained group of military experts known for their strength, stealth and speed. Some of their training is coming from doctors and nurses at the Virginia Commonwealth University Medical Center.
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.
European scientists recently discovered a novel therapy to treat a subgroup of patients with hereditary breast/ovarian cancer. Both the EU and the US have approved an accelerated procedure to market this promising new treatment with few side effects.
Topera Medical today announced that its FDA-cleared RhythmView 3D mapping and diagnostic system will be featured in 16 scientific presentations at the 33rd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 9-12 in Boston.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roger K Khouri, MD 2734 Sw 37th Ave, Coconut Grove, FL 33133-2728 Ph: (305) 642-4260 | Dr Roger K Khouri, MD 2734 Sw 37th Ave, Coconut Grove, FL 33133-2728 Ph: (305) 642-4260 |
News Archive
They call themselves quiet professionals - an elite, highly trained group of military experts known for their strength, stealth and speed. Some of their training is coming from doctors and nurses at the Virginia Commonwealth University Medical Center.
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.
European scientists recently discovered a novel therapy to treat a subgroup of patients with hereditary breast/ovarian cancer. Both the EU and the US have approved an accelerated procedure to market this promising new treatment with few side effects.
Topera Medical today announced that its FDA-cleared RhythmView 3D mapping and diagnostic system will be featured in 16 scientific presentations at the 33rd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 9-12 in Boston.
› Verified 9 days ago